Grafts/flaps in traumatic wounds with significant edema and tissue compromise.
Grafts/flaps in traumatic wounds with significant edema and tissue compromise.
Pale, cool flaps with poor or absent cap refill indicating inadequate arterial inflow.
Distal flap necrosis from inadequate random blood supply, pedicle tension, or torsion.
Distal flap necrosis from inadequate random blood supply, pedicle tension, or torsion.
Grafts/flaps placed on previously irradiated tissue with compromised vascularity and impaired healing capacity.
HBOT is not for routine grafts or flaps with normal healing. It's a salvage tool for compromised tissue — when something has gone wrong and the graft or flap is at risk of failure without intervention.
— Undersea and Hyperbaric Medical Society (UHMS)
"Hyperbaric oxygen therapy is neither necessary nor recommended for the support of normal, uncompromised grafts or flaps. However, in tissue compromised by irradiation or in other cases where there is decreased perfusion or hypoxia, HBO₂T has been shown to be extremely useful in flap salvage."
Enhances collagen synthesis and tissue remodeling for graft take
Stimulates new capillary growth for permanent vascular improvement
Vasoconstriction reduces tissue swelling while maintaining oxygen delivery
Plasma oxygen increased 10-15×, reaching tissue RBCs cannot access
Early recognition is critical. The sooner HBOT begins after identifying compromise, the better the chance of salvage.
HBOT should be initiated within 48-72 hours of recognizing compromise. Studies show significantly better outcomes with earlier intervention. For acute cases (crush injury, replantation), treatment within 4-6 hours of injury is ideal when possible.
Total sessions (typical)
Acute phase (first 48-72 hrs)
Session duration
Treatment pressure
Sources: Undersea Hyperb Med 2020; Laryngoscope 2022; PMC 2016; Bouachour et al. RCT
Time to granulation: 25% shorter with HBOT, enabling earlier reconstruction
Mastectomy flaps: 9/10 patients achieved successful flap healing with early HBOT
Salvage rate: 75.7% successful salvage of failed grafts/flaps (30 treatments avg.)
Crush injuries: 94% complete healing with HBOT vs. 56% sham (RCT)
Flap necrosis: 3× less likely with adjuvant HBOT (15% vs. 51%)
Graft loss: Reduced from 52% to 23% in HBOT-treated group
Flap survival: 62-97% with HBOT vs. 35-78% in controls across multiple studies
Compromised grafts and flaps is an FDA-approved indication. Coverage varies by plan, but most insurers cover it when there's documented evidence of compromise. We verify benefits and can expedite authorization for urgent cases.
HBOT helps both arterial insufficiency and venous congestion. The edema-reducing effect of hyperoxygenation can improve venous outflow, while the direct oxygen delivery supports tissue survival regardless of the mechanism of compromise.
Yes. For high-risk wound beds (radiation-damaged tissue, diabetic wounds, chronic wounds), preoperative HBOT can improve vascularity and tissue oxygenation before reconstruction. This is a separate indication from acute graft/flap salvage.
For urgent surgical cases, we can often begin treatment the same day. Time is critical — call us as soon as you identify compromise. We'll coordinate with your team to initiate therapy as rapidly as possible.
No. HBOT is not indicated for normal, uncompromised grafts or flaps. It's a salvage therapy for tissue that is failing or at high risk of failure — such as grafts on irradiated beds, ischemic flaps, or tissue affected by crush injury.